NCT04219059View on ClinicalTrials.gov

MR Radiomic Features in Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 3, 2019

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
Prostate Cancer
Trial Locations (1)

20153

IRCCS Ospedale San Raffaele, Milan

All Listed Sponsors
collaborator

IBFM-CNR (Istituto di Bioimmagini e Fisiologia Molecolare, National Research Council, Segrate, Italy

UNKNOWN

lead

IRCCS San Raffaele

OTHER

NCT04219059 - MR Radiomic Features in Prostate Cancer | Biotech Hunter | Biotech Hunter